SCHEMBL2201275

SCHEMBL2201275

O=C(NS(=O)(=O)c1ccc(Oc2ccccc2)cc1)c1ccc(C(=O)C(F)(F)F)s1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 8/20 0.54
BCL2L1 Q07817 7/20 0.54
HDAC1 Q13547 7/20 0.49
HDAC6 Q9UBN7 7/20 0.49
HDAC4 P56524 6/20 0.49
HDAC3 O15379 5/20 0.49
TARS1 P26639 1/20 0.46
MMP2 P08253 4/20 0.45
CA12 O43570 3/20 0.45
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA9 Q16790 3/20 0.45
ADAMTS4 O75173 1/20 0.43
MMP1 P03956 1/20 0.43
MMP13 P45452 1/20 0.43
MMP14 P50281 1/20 0.43
MEP1B Q16820 1/20 0.43
ADAMTS5 Q9UNA0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767789 0.86 HDAC6 (0.52) MCL1BCL2L1HDAC1HDAC6HDAC4
SCHEMBL2200105 0.85 HDAC1 (0.46) HDAC1HDAC6HDAC4HDAC3MMP2
SCHEMBL2229957 0.82 HDAC1 (0.47) MCL1BCL2L1HDAC1HDAC6HDAC4
SCHEMBL2203868 0.80 PGR (0.55) HDAC1HDAC6HDAC4HDAC3
SCHEMBL2203242 0.77 HDAC1 (0.79) HDAC1HDAC6HDAC4HDAC3MMP13
SCHEMBL2204328 0.77 CA1 (0.49) HDAC1HDAC6HDAC4MMP2CA12
SCHEMBL2202722 0.76 FLT1 (0.51) MCL1BCL2L1HDAC1HDAC6HDAC4
SCHEMBL2203343 0.75 HDAC1 (0.80) MCL1HDAC1HDAC6HDAC4HDAC3
SCHEMBL2200633 0.75 HDAC6 (0.50) HDAC1HDAC6HDAC4HDAC3
SCHEMBL2200241 0.74 HDAC6 (0.50) HDAC1HDAC6HDAC4HDAC3CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP claimed
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP disclosed
US-7977374-B2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-12 US disclosed
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors MSD ITALIA S.R.L. (IT) 2009-06-18 US disclosed
EP-1926721-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2008-06-04 EP disclosed
WO-2007029035-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors HDAC1, HDAC2, HDAC11 MCL1 1603/4885BCL2L1 1912/4885HDAC1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.